Studies have indicated that PD-1 treatment imparted significant benefits to HCC patients with a higher abundance of intestinal microorganisms, such as Lachnospiraceae bacterium GAM79 and Alistipes sp. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.